Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Darsow

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Journal of Investigational Allergology & Clinical Immunology|May 30, 2009
Benefits of alpine mountain climate of Bavaria in patients with allergic diseases and chronic obstructive pulmonary disease: results from the AURA* studyB Eberlein, A Gulyas, K Schultz, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 13, 2005
Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adultsS Weidinger, N Klopp, L Rümmler, et al.
International Archives of Allergy and Immunology|August 26, 2006
No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patientsJ M Oldhoff, U Darsow, T Werfel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 24, 2016
ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patientsA Wollenberg, A Oranje, M Deleuran, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 27, 2012
[Assessment of pruritus - current standards and implications for clinical practice : consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)]S Ständer, C Blome, B Breil, et al.
Allergy|April 9, 2005
Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitisJ M Oldhoff, U Darsow, T Werfel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 5, 2005
Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology ForumJ Ring, J Barker, H Behrendt, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 21, 2012
Guidelines for treatment of atopic eczema (atopic dermatitis) Part IIJ Ring, A Alomar, T Bieber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 19, 2012
Guidelines for treatment of atopic eczema (atopic dermatitis) part IJ Ring, A Alomar, T Bieber, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Journal of Investigational Allergology & Clinical Immunology|May 30, 2009
Benefits of alpine mountain climate of Bavaria in patients with allergic diseases and chronic obstructive pulmonary disease: results from the AURA* studyB Eberlein, A Gulyas, K Schultz, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 13, 2005
Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adultsS Weidinger, N Klopp, L Rümmler, et al.
International Archives of Allergy and Immunology|August 26, 2006
No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patientsJ M Oldhoff, U Darsow, T Werfel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 24, 2016
ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patientsA Wollenberg, A Oranje, M Deleuran, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 27, 2012
[Assessment of pruritus - current standards and implications for clinical practice : consensus paper of the Action Group Pruritus Parameter of the International Working Group on Pruritus Research (AGP)]S Ständer, C Blome, B Breil, et al.
Allergy|April 9, 2005
Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitisJ M Oldhoff, U Darsow, T Werfel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 5, 2005
Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology ForumJ Ring, J Barker, H Behrendt, et al.
Allergy|November 23, 2016
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paperO Pfaar, K Bastl, U Berger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 21, 2012
Guidelines for treatment of atopic eczema (atopic dermatitis) Part IIJ Ring, A Alomar, T Bieber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 19, 2012
Guidelines for treatment of atopic eczema (atopic dermatitis) part IJ Ring, A Alomar, T Bieber, et al.
Pageof 11